All In Biotech

Drug Trial Radar · NCT05422378

A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty

A Phase 1 Study to Evaluate the Safety and Tolerability of Subcutaneous Injection of STP705 in Adult Subjects Undergoing Abdominoplasty

Last checked: Nov 19, 2026Latest source record: Mar 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

Aug 1, 2022

Primary completion

Feb 3, 2023

Study completion Jun 27, 2023

Sponsor

Lead sponsor
SirnaomicsIndustry
Sponsor type
Industry
First posted
Jun 16, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Dose-ranging, randomized, double-blind, vehicle-controlled study

Conditions

  • Abdominal Obesity

Interventions

  • STP705Drug

    STP705 composed of 2 siRNA targeting TGF-B1and COX-2 individually.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subjects with presence and severity of the following Local Skin Reactions (LSR): erythema, edema, bruising.Time frame: 24 weeks
  2. Number of subjects with presence and severity of the following Local Skin Reactions (LSR): pain and stinging/burning.Time frame: 24 weeks
  3. Incidence (severity and causality) of any AEsTime frame: 24 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Center for Clinical and Cosmetic Research

    Aventura, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.